StonvexLoading…
StonvexStonvexStonvexCore line items from AIM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.00K | $88.00K | $67.00K | $41.00K |
Operating Income | $-2.23M | $-11.66M | $-8.71M | $-6.26M |
Net Income | $-3.02M | $-13.96M | $-9.78M | $-2.79M |
EPS (Diluted) | $-0.69 | $-8.62 | $-8.18 | $-8.88 |
Total Assets | $8.59M | $5.78M | $5.49M | $4.13M |
Total Liabilities | $6.46M | $15.56M | $11.57M | $10.68M |
Cash & Equivalents | $5.82M | $2.98M | $2.35M | $476.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 8.22M | 3.07M | 2.76M | 764.19K |